ID   CHLA-02-ATRT
AC   CVCL_B045
SY   CHLA-02
DR   ATCC; CRL-3020
DR   BioSample; SAMN03471711
DR   Wikidata; Q54812138
RX   PubMed=25211508;
RX   PubMed=25638158;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-3020
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D21S11: 29,33.2
ST   D2S1338: 17,21
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 20,22
ST   Penta D: 10,12
ST   Penta E: 7,10
ST   TH01: 6
ST   TPOX: 10,12
ST   vWA: 16,18
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 13
//
RX   PubMed=25211508; DOI=10.1002/jcb.24976; PMCID=PMC10656279;
RA   Xu J., Margol A.S., Asgharzadeh S., Erdreich-Epstein A.;
RT   "Pediatric brain tumor cell lines.";
RL   J. Cell. Biochem. 116:218-224(2015).
//
RX   PubMed=25638158; DOI=10.18632/oncotarget.3078; PMCID=PMC4413645;
RA   Weingart M.F., Roth J.J., Hutt-Cabezas M., Busse T.M., Kaur H.,
RA   Price A., Maynard R., Rubens J., Taylor I.C., Mao X.-G., Xu J.-Y.,
RA   Kuwahara Y., Allen S.J., Erdreich-Epstein A., Weissman B.E., Orr B.A.,
RA   Eberhart C.G., Biegel J.A., Raabe E.H.;
RT   "Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the
RT   importance of the mitogen activated protein kinase pathway as a
RT   therapeutic target.";
RL   Oncotarget 6:3165-3177(2015).
//